Our study further elucidated the critical role of SIRT1 in the occurrence and development of NPC, which provided the necessary experimental data and theoretical basis for the application of EGCG in the prevention and treatment of NPCs. The gene discussed is SIRT1; the disease is nasopharyngeal carcinoma.